Daily Roundup

Friday, 6th February 2026
Last updated: 21:00 | Max Version 🚀

REA.ASX ACE.ASX CTQ.ASX HMC.ASX GSS.ASX

REA Group Delivers Strong Yield Growth in H1

REA Group Ltd (ASX:REA) has reported a strong financial performance for the first half of FY26. Revenue grew 5% to $916 million, EBITDA was up 6% to $569 million, and net profit increased 9% to $341 million.

The company's core residential business saw double-digit yield growth of 14%, partially offsetting a 6% decline in national listings. Residential revenue increased 7%, driven by the yield improvement. Commercial & New Homes revenue grew 10%, while Financial Services revenue was up 11%.

REA's flagship site, realestate.com.au, extended its audience leadership, reaching record monthly visits and unique visitors. In India, the company simplified its business structure and is focusing on the Housing.com portal. Move, Inc. in North America saw a 10% revenue increase.

Operating costs grew by 3%, or 8% adjusted for M&A activity. The company announced an on-market share buy-back of up to $200 million and an interim dividend of $1.24 per share, up 13%.

Looking ahead, the Australian property market is experiencing strong buyer demand nationally. REA Group is well-positioned for further growth in the remainder of FY26 through innovation, new product features and capabilities, and ongoing strength in property market fundamentals.

REA Group Reports H1 FY26 Results

REA Group has reported a strong financial performance for the half-year ended 31 December 2025. Revenue increased 5% to $915.8 million, and net profit from core operations grew 9% to $340.6 million.

The company's Australian operations continued to perform well, with revenue from the Property & Online Advertising segment rising 8% to $814.0 million. The Financial Services division also saw an 11% increase in revenue to $57.8 million.

In India, the company's strategic focus on the Housing.com portal has resulted in a 40% decline in revenue, while the newly acquired iGUIDE business in North America contributed $5.9 million.

The REA Group Board has determined to pay an interim dividend of $1.24 per share, fully franked, an increase of 13% compared to the prior period.

Acusensus Settles Legal Dispute with Redflex

Acusensus Limited (ASX:ACE) has reached a global settlement with Redflex Traffic Systems Pty Ltd, resolving the Federal Court proceedings initiated by Redflex in June 2025. The settlement involves a $6 million cash payment and the issue of 6.1 million new Acusensus shares to Verra Mobility.

Importantly, Acusensus retains ownership of its patent portfolio and can continue using its technology. This outcome allows the company to continue delivering its services to customers and grow its business without the distraction and ongoing costs of the litigation.

Careteq Signs Binding Agreement for Sale of EHS Business

Careteq Limited (ASX: CTQ) has entered into a binding sale agreement to divest its fully owned subsidiary, Embedded Health Solutions (EHS), to Nationwide Investments Holdings Pty Ltd for $5 million, subject to shareholder approval.

The sale of EHS will enable Careteq to recalibrate its balance sheet and focus on growing its HMR Referral marketplace platform for home medication reviews in the home care sector. The divestment will also position the company to better defend its position against the ATO and its current R&D claims.

HMC Capital Establishes Energy Transition Partnership with KKR

HMC Capital (ASX: HMC) has announced a strategic partnership with KKR, under which KKR will invest up to $603 million into HMC's Energy Transition Platform. The funding will support the development of HMC's 5.7GW BESS and wind pipeline, enabling the company to play a major role in Australia's transition to net zero carbon by 2050.

The partnership is expected to deliver significant benefits to HMC shareholders and is consistent with the company's strategy to build scalable and high-return platforms. The transaction is subject to regulatory approvals and is expected to close in mid-2026.

GSS Appoints Anne Lockwood as Interim Managing Director

Genetic Signatures Limited (ASX:GSS) has appointed Non-Executive Director Anne Lockwood as interim Managing Director, strengthening the company's leadership team and positioning it for strategic execution.

Mrs. Lockwood brings over 30 years of experience in finance, risk management, and audit, including deep expertise in mergers and acquisitions and capital market transactions. She will work closely with the newly appointed CEO, Maria Halasz, to support the execution of the company's strategy while maintaining strong financial oversight.

Mrs. Lockwood will assume the role for a six-month period, after which the Board will review the company's longer-term management arrangements.